Canilang, Baby Boy .
HRN: 25-29-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2024
MUPIROCIN 2%, 15G (TUBE)
06/20/2024
06/26/2024
TOPICAL
1
BID
Bacterial Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes